Education
About Us
Working with TipRanks
Follow Us
BioNxt Solutions (TSE:BNXT)
:BNXT
BNXT Stock Chart & Stats
C$0.61
-C$0.02(-3.85%)
At close: 4:00 PM EST
C$0.61
-C$0.02(-3.85%)
Day’s Range― - ―
52-Week RangeC$0.30 - C$1.10
Previous CloseN/A
Volume110.36K
Average Volume (3M)80.86K
Market Cap
C$74.30M
Enterprise ValueN/A
Total Cash (Recent Filing)C$468.76K
Total Debt (Recent Filing)C$8.33M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
Apr 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding121,810,260
10 Day Avg. Volume59,081
30 Day Avg. Volume80,860
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)-5.39
Price to Sales (P/S)1568.84
P/FCF Ratio-13.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BioNxt Solutions News
BNXT FAQ
What was BioNxt Solutions’s price range in the past 12 months?
BioNxt Solutions lowest stock price was C$0.30 and its highest was C$1.10 in the past 12 months.
What is BioNxt Solutions’s market cap?
BioNxt Solutions’s market cap is C$74.30M.
When is BioNxt Solutions’s upcoming earnings report date?
BioNxt Solutions’s upcoming earnings report date is Apr 29, 2026 which is in 125 days.
How were BioNxt Solutions’s earnings last quarter?
BioNxt Solutions released its earnings results on Nov 26, 2025. The company reported -C$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.014.
Is BioNxt Solutions overvalued?
According to Wall Street analysts BioNxt Solutions’s price is currently Overvalued.
Does BioNxt Solutions pay dividends?
BioNxt Solutions does not currently pay dividends.
What is BioNxt Solutions’s EPS estimate?
BioNxt Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioNxt Solutions have?
BioNxt Solutions has 121,810,260 shares outstanding.
What happened to BioNxt Solutions’s price movement after its last earnings report?
BioNxt Solutions reported an EPS of -C$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.429%.
Which hedge fund is a major shareholder of BioNxt Solutions?
Currently, no hedge funds are holding shares in TSE:BNXT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BioNxt Solutions
BioNxt Solutions (BNXT) is a biotechnology company focused on developing innovative solutions for the healthcare and life sciences sectors. The company specializes in bioanalytical tools and technologies that enhance drug development processes and improve patient outcomes. BNXT’s core products include advanced diagnostic assays and biopharmaceutical solutions that cater to a diverse range of applications, from clinical research to personalized medicine.
Technical Analysis
Mountain Valley MD
―
Medicure
―
Medexus Pharmaceuticals Inc
―
Revive Therapeutics
―
InnoCan Pharma
―
Options Prices
Currently, No data available
---